Contents: 3 Transdermal Systems | Rx only
(norelgestromin and ethinyl
estradiol transdermal system)
150/35 mcg per day
Each 14 cm2 system contains 4.86 mg norelgestromin, USP and 0.53 mg ethinyl estradiol, USP. The inactive components are crospovidone, dipropylene glycol, fluoropolymer coated polyester film, light mineral oil, non-woven polyester fabric, oleyl alcohol, polyethylene/polyester film and polyisobutene adhesive. Each patch is printed with brown ink.
This product is intended to prevent pregnancy. It does not protect against HIV infection (AIDS) and other sexually transmitted diseases.
For Transdermal Use Only
See patient instructions. Apply immediately upon removal
from pouch. Each transdermal system is intended to be
worn 7 days as prescribed.
Package not child-resistant. Keep out of reach of
Do not store unpouched. Store at 20° to 25°C
(68° to 77°F). [See USP Controlled Room Temperature.]
Mylan Pharmaceuticals Inc.
Morgantown, WV 26505 U.S.A.
| XULANE |
norelgestromin and ethinyl estradiol patch
|Labeler — Mylan Pharmaceuticals Inc. (059295980)|
Revised: 04/2020 Mylan Pharmaceuticals Inc.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.